← Leaderboards
James W Geddes
University Of Kentucky
$9,073,491
Attributed
$10,224,737
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$14,996,706 · 14
By mechanism
P01$7,931,820 · 4
R01$4,797,256 · 3
T32$712,153 · 1
P30$574,331 · 1
P50$432,752 · 1
R21$412,865 · 1
Top collaborators
- Edward D Hall6 shared
- Patrick G Sullivan5 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Edward D Hall$10,672,048
- Michal J. Toborek$37,025,871
- Philip W. Landfield$13,634,726
- Patrick G Sullivan$10,466,531
- Jacqueline Renee Kulbe$171,524
Others in their field
Top investigators on “Calpain”
- Naren L Banik · Medical University Of South Carolina$13,192,318
- Kenneth D. Tew · Fox Chase Cancer Center$10,798,252
- Melissa Jan Spencer · University Of California Los Angeles$9,310,831
- Edward D Hall · University Of Kentucky$7,363,646
- Alexander J Varshavsky · California Institute Of Technology$7,221,759
- Alan Wells · Veterans Health Administration$7,066,076
Research focus
CalpainTraumatic Brain InjuryNeuronsBaseCessation Of LifeCaspaseMitochondriaCell DeathProteolysisTissuesInjuryInhibitor/AntagonistNerve DegenerationCleaved CellAttenuatedProteinsCellsSignal TransductionCytoskeletal ProteinsApoptosis Inducing FactorIn VivoNecrosisLaboratory RatExhibits
Grant awards (58)
CNS Functions of Calpain 5$320,887
R01 · FY2020 · NS · contact PI
CNS Functions of Calpain 5$345,297
R01 · FY2019 · NS · contact PI
CNS Functions of Calpain 5$396,011
R01 · FY2018 · NS · contact PI
CNS Functions of Calpain 5$396,011
R01 · FY2017 · NS · contact PI
Neurobiology of CNS Injury and Repair$756
T32 · FY2017 · NS
CNS Functions of Calpain 5$416,217
R01 · FY2016 · NS · contact PI
Neurobiology of CNS Injury and Repair$89,467
T32 · FY2016 · NS
Novel Biomarkers of TBI Identified Using Phage Display$187,865
R21 · FY2015 · NS · contact PI
Neurobiology of CNS Injury and Repair$157,718
T32 · FY2015 · NS
Novel Biomarkers of TBI Identified Using Phage Display$225,000
R21 · FY2014 · NS · contact PI
Neurobiology of CNS Injury and Repair$156,448
T32 · FY2014 · NS
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$307,205
R01 · FY2013 · NS · contact PI
Neurobiology of CNS Injury and Repair$153,882
T32 · FY2013 · NS
FASEB SRC on The Biology of Calpains in Health and Disease$22,000
R13 · FY2013 · NS · contact PI
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$318,347
R01 · FY2012 · NS · contact PI
Neurobiology of CNS Injury and Repair$153,882
T32 · FY2012 · NS
Calpain as a Therapeutic Target for TBI (P01)$945,555
P01 · FY2011 · NS · contact PI
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$318,347
R01 · FY2011 · NS · contact PI
Is u-calpain a pathologic isoform?$210,629
P01 · FY2011 · NS · contact PI
Calpain as a Therapeutic Target for TBI (P01)$945,560
P01 · FY2010 · NS · contact PI
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$321,596
R01 · FY2010 · NS · contact PI
Is u-calpain a pathologic isoform?$210,626
P01 · FY2010 · NS · contact PI
FASEB Summer Research Conference: The Biology of Calpains in Health and Disease$28,000
R13 · FY2010 · NS · contact PI
Calpain as a Therapeutic Target for TBI (P01)$922,518
P01 · FY2009 · NS · contact PI
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$324,844
R01 · FY2009 · NS · contact PI
Is u-calpain a pathologic isoform?$206,644
P01 · FY2009 · NS · contact PI
Core--Bioinformatics$111,844
P30 · FY2009 · NS · contact PI
Calpain as a Therapeutic Target for TBI (P01)$82,849
P01 · FY2009 · NS · contact PI
Calpain as a Therapeutic Target for TBI (P01)$73,894
P01 · FY2009 · NS · contact PI
Calpain as a Therapeutic Target for TBI (P01)$895,644
P01 · FY2008 · NS · contact PI
MITOCHONDRIA, ROS, CA2+, AND CAPLAIN IN THE AGING CNS$222,276
P01 · FY2008 · AG · contact PI
Is u-calpain a pathologic isoform?$200,625
P01 · FY2008 · NS · contact PI
Core--Bioinformatics$109,806
P30 · FY2008 · NS · contact PI
Calpain as a Therapeutic Target for TBI (P01)$905,949
P01 · FY2007 · NS · contact PI
Calpain Inhibition Strategies for Spinal Cord Injury$322,980
R01 · FY2007 · NS · contact PI
MITOCHONDRIA, ROS, CA2+, AND CAPLAIN IN THE AGING CNS$201,818
P01 · FY2007 · AG · contact PI
Is u-calpain a pathologic isoform?$185,483
P01 · FY2007 · NS · contact PI
Core--Bioinformatics$110,052
P30 · FY2007 · NS · contact PI
Administration and statistics$67,570
P01 · FY2007 · NS · contact PI
Mechanisms of Neurologic Disease Course$43,333
R25 · FY2007 · MH · contact PI
Calpain Inhibition Strategies for Spinal Cord Injury$332,627
R01 · FY2006 · NS · contact PI
MITOCHONDRIA, ROS, CA2+, AND CAPLAIN IN THE AGING CNS$180,504
P01 · FY2006 · AG · contact PI
Core--Bioinformatics$110,126
P30 · FY2006 · NS · contact PI
Mechanisms of Neurologic Disease Course$42,196
R25 · FY2006 · MH · contact PI
Calpain Inhibition Strategies for Spinal Cord Injury$340,631
R01 · FY2005 · NS
MITOCHONDRIA, ROS, CA2+, AND CAPLAIN IN THE AGING CNS$175,049
P01 · FY2005 · AG
Core--Bioinformatics$132,503
P30 · FY2005 · NS
Calpain Inhibition Strategies for Spinal Cord Injury$336,256
R01 · FY2004 · NS
MITOCHONDRIA, ROS, CA2+, AND CAPLAIN IN THE AGING CNS$170,878
P01 · FY2004 · AG
ROLE OF CALCIUM, CALPAINS, AND CASPASES IN NEURODEGENERATION$230,705
P01 · FY2002 · AG
NEURONAL INSULT AND CYTOSKELETAL DISRUPTION$0
P50 · FY2002 · AG
NEURONAL INSULT AND CYTOSKELETAL DISRUPTION$254,615
P50 · FY2001 · AG
ROLE OF CALCIUM, CALPAINS, AND CASPASES IN NEURODEGENERATION$230,705
P01 · FY2001 · AG
ROLE OF CALCIUM, CALPAINS, AND CASPASES IN NEURODEGENERATION$228,404
P01 · FY2001 · AG
NEURONAL INSULT AND CYTOSKELETAL DISRUPTION$0
P50 · FY2001 · AG
ROLE OF CALCIUM, CALPAINS, AND CASPASES IN NEURODEGENERATION$228,404
P01 · FY2000 · AG
ROLE OF CALCIUM, CALPAINS, AND CASPASES IN NEURODEGENERATION$209,531
P01 · FY2000 · AG
Recovery from cytoskeletal disruption$178,137
P50 · FY2000 · AG